CardioTech Presents Brazilians Living with CardioPass Graft

Massachusetts-based CardioTech International Inc. announced that it will make a presentation at the 32nd Congress of the Brazilian Society for Cardiovascular Surgery on April 29, 2005 in Vitoria, Brazil, on its synthetic coronary bypass graft. 

The presentation will include an update on the three Brazilian “no-option” patients who participated in the Phase I human clinical trials, an overview of the proposed clinical protocol for conducting Phase II trials, and a discussion of the technology utilized in the manufacture of the CardioPass synthetic coronary artery bypass graft. 


After one and one half years post-implantation, all three patients are leading normal lives and are asymptomatic, a remarkable clinical achievement.


Presenting will be Dr. Michael Szycher, the company’s Chief Executive Officer and founder, who previously was a member of the Thermedics team that developed the HeartMate, a left ventricular assist device (LVAD), and who also founded PolyMedica Corporation. 


Thermedics and PolyMedica are manufacturers of innovative cardiovascular medical devices.  The presentation will be entitled: “A Report from the Inventor of the CardioPass Synthetic Coronary Artery Bypass Graft”.


Joining Dr. Szycher in the presentation will be Professor Ivo Nesralla and Dr. Guaracy Texeira, who will be distributing and discussing the clinical protocol to the international audience of heart surgeons. 


Professor Ivo Nesralla is the Chairman of Cardiac Surgery and President of the Instituto de Cardiologia do Rio Grande do Sul of Porto Alegre, Brazil. 


Dr. Nesralla is one of the pioneering surgeons who successfully completed the first HeartMate LVAD surgery in Brazil.  Dr. Texeira is a senior cardiovascular surgeon on the staff of the Institute who developed the protocol that will be used in Brazil.


CardioTech’s current plans are to enroll a total of 30 patients, who will be followed 6 months angiographically, plus an additional 6 months clinical assessment, for a total of 12 months post-operatively.  They expect to receive Brazilian Phase II approval by mid 2005.


The CardioPass synthetic coronary artery bypass graft was designed to mimic the human saphenous veins in biomechanical properties.  Any surgeon should be able to implant these grafts without any additional training since the surgical implantation protocol is identical to current procedures that have been in use for decades throughout the world. 


The trials will be conducted on “no option” patients who, having had failed previous bypass operations, are now in need of a “re-do” procedure.


CardioTech International Inc.
www.cardiotech-inc.com


PRNewswire

Tags:

  • Show Comments (0)

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

In Quality of Life Brazil Ranks 48, US 5, France 1, Iraq Last

France offers the greatest quality of life in the world, according to the latest ...

Going Nuclear Is the Answer, Brazil Finds Out

Although Brazil has an enormous hydroelectric potential (estimated at almost 260,000 MW), only 68,000 ...

Condom in Brazil is known popularly as camisinha, little shirt

If You Are 13 and in School You Are Entitled to a Free Condom in Brazil

After finding out that 45% of Brazil's high-school students have an active sexual life ...

Spain Ready to Help Brazil Enforce Mandatory Classes of Spanish

The first vice president of Spain, Maria Teresa Fernandez de La Vega, says her ...

Ayrton Senna’s Legacy Has Touched Over 9 Million Brazilian Kids

This year’s Brazilian Formula One race was one of the most exciting ever. The ...

Chevron Expected to Pay US$ 100 Million in Fines for Spilling Oil Off Rio’s Coast

Brazil’s National Petroleum Agency (ANP), the Brazilian Institute of Environment and Natural Resources (IBAMA) ...

The Case for Federal Intervention in Brasília. Would It Make Any Difference?

On April 21, Brazilian capital Brasília will celebrate its 50th anniversary. A question on ...

Monsanto Buys World’s Largest Sugarcane Breeding Firm in Brazil

US-based agriculture company Monsanto has completed the purchase of Brazilian firm Aly Participações Ltda., ...

Brazil Taps Money from US$ 207 Billion Foreign Reserves to Fund Exports

Henrique Meirelles, the president of Brazil's Central Bank (BC)announced Monday, October 6, that his ...